These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 12042191

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
    Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW.
    J Clin Psychiatry; 2002 Dec; 63(12):1148-55. PubMed ID: 12523875
    [Abstract] [Full Text] [Related]

  • 5. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T, Brown E, Schuh LM, Baker RW, Tohen M.
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [Abstract] [Full Text] [Related]

  • 6. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Dec; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.
    Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V.
    Am J Psychiatry; 1999 May; 156(5):702-9. PubMed ID: 10327902
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
    Tohen M, Vieta E, Goodwin GM, Sun B, Amsterdam JD, Banov M, Shekhar A, Aaronson ST, Bardenstein L, Grecu-Gabos I, Tochilov V, Prelipceanu D, Oliff HS, Kryzhanovskaya L, Bowden C.
    J Clin Psychiatry; 2008 Nov; 69(11):1776-89. PubMed ID: 19014751
    [Abstract] [Full Text] [Related]

  • 10. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
    Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, Lawson WB, Emsley RA, Zhang F, Baker RW, Risser RC, Namjoshi MA, Evans AR, Breier A.
    Arch Gen Psychiatry; 2003 Dec; 60(12):1218-26. PubMed ID: 14662554
    [Abstract] [Full Text] [Related]

  • 11. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania.
    Chengappa KN, Baker RW, Shao L, Yatham LN, Tohen M, Gershon S, Kupfer DJ.
    Bipolar Disord; 2003 Feb; 5(1):1-5. PubMed ID: 12656931
    [Abstract] [Full Text] [Related]

  • 12. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [Abstract] [Full Text] [Related]

  • 13. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    Hirschfeld RM, Baker JD, Wozniak P, Tracy K, Sommerville KW.
    J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Divalproex versus olanzapine in mania.
    Vieta E.
    J Clin Psychiatry; 2003 Oct; 64(10):1266; author reply 1266-7. PubMed ID: 14658978
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.
    Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzalez-Heydrich J, Risser RC, Nowlin ZM.
    J Child Adolesc Psychopharmacol; 2001 Oct; 11(3):239-50. PubMed ID: 11642474
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.